Oklo, Centrus Energy, NuScale Power, BWX Technologies, Nano Nuclear Energy, Lightbridge, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat's stock screener tool. Nuclear stocks are shares of publicly traded companies whose core businesses involve nuclear energy—ranging from uranium mining and fuel processing to reactor construction and related services. Investors buy these equities to gain targeted exposure to the nuclear sector’s long-term growth potential amid global decarbonization and energy-security trends. Because they depend heavily on regulatory approvals, technological developments and geopolitical dynamics, nuclear stocks often carry risk-and-reward profiles that differ from broader market indexes. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.
Oklo (OKLO)
Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.
Read Our Latest Research Report on OKLO
Centrus Energy (LEU)
Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.
Read Our Latest Research Report on LEU
NuScale Power (SMR)
NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.
Read Our Latest Research Report on SMR
BWX Technologies (BWXT)
BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.
Read Our Latest Research Report on BWXT
Nano Nuclear Energy (NNE)
Read Our Latest Research Report on NNE
Lightbridge (LTBR)
Read Our Latest Research Report on LTBR
Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).
Read Our Latest Research Report on KPTI
See Also
Before you consider Oklo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oklo wasn't on the list.
While Oklo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.